Evidence map›Paper›PMID 39954040›Full record

ArticleJournal of thrombosis and thrombolysis2025

Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment.

Lucio D'Anna, Matteo Foschi, Luke Dixon, Francesco Bax, Viva Levee, Feras Fayez, Lucinda Knight, Arianna Cella, Alessandro Mare', Fedra Kuris and 10 more

Abstract read
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Biomarkers, mechanisms, and precision care in thrombosis.Journal of thrombosis and thrombolysis · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Lucio D'AnnaDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK. l.danna@imperial.ac.uk.ORCID http://orcid.org/0000-0002-4349-3322
Matteo FoschiDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Luke DixonNeuroradiology, Department of Imaging, Charing Cross Hospital, Imperial College London, NHS Healthcare Trust, London, UK.
Francesco BaxDepartment of Neurology, Philip Kistler Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Viva LeveeDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Feras FayezDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Lucinda KnightDepartment of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Arianna CellaStroke Unit and Clinical Neurology, Udine University Hospital, Udine, Italy.
Alessandro Mare'Stroke Unit and Clinical Neurology, Udine University Hospital, Udine, Italy.
Fedra KurisStroke Unit and Clinical Neurology, Udine University Hospital, Udine, Italy.
Sara PezStroke Unit and Clinical Neurology, Udine University Hospital, Udine, Italy.
Massimo SponzaClinical Neurology, Udine University Hospital and DAME, University of Udine, Udine, Italy.
Kyriakos LobotesisNeuroradiology, Department of Imaging, Charing Cross Hospital, Imperial College London, NHS Healthcare Trust, London, UK.
Thanh NguyenDepartment of Neurology, Radiology, Boston Medical Center, Boston, MA, USA.
Simona SaccoDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Gian Luigi GigliClinical Neurology, Udine University Hospital and DAME, University of Udine, Udine, Italy.
Mariarosaria ValenteClinical Neurology, Udine University Hospital and DAME, University of Udine, Udine, Italy.
Soma Banerjee *Department of Stroke and Neuroscience, Charing Cross Hospital, Imperial College London NHS Healthcare Trust, London, UK.
Giovanni Merlino *Stroke Unit and Clinical Neurology, Udine University Hospital, Udine, Italy.
Study Investigators*

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some patients with large vessel occlusion (LVO) achieve insufficient clinical improvement (futile recanalization, FR) after intravenous thrombolysis (IVT) during inter-hospital transfer for thrombectomy, while others show good outcomes (effective recanalization, ER). This study assessed FR and ER rates among patients treated with IVT at non-thrombectomy primary stroke centers (PSCs) and aimed to identify predictors of FR. We analyzed data from two PSC registries (2016-2022). Inclusion criteria: IVT treatment, anterior circulation LVO, NIHSS ≥ 6, ASPECTS ≥ 5, and documented recanalization at thrombectomy centers. FR was defined as a 90-day poor outcome (mRS 3-6) despite LVO recanalization on initial angiography. Among 190 PSC patients with documented recanalization post-IVT, 113 (59.5%) had FR. Multivariable analysis identified age (OR = 1.03, 95%CI = 1.01-1.07, p = 0.021), NIHSS at the PSC (OR = 1.13, 95%CI = 1.05-1.22, p = 0.026), and collateral status (OR = 0.54, 95%CI = 0.39-0.75, p = 0.001) as independent predictors of FR and 90-day mortality. A model combining age, NIHSS, and collateral score provided the highest predictive accuracy for FR and mortality. FR is common in LVO-related ischemic stroke treated with IVT at non-thrombectomy centers. FR is common in LVO-related ischemic stroke treated with IVT at non-thrombectomy centers. Identifying predictors of FR can guide clinicians in early decision-making, allowing for tailored interventions and informed discussions about expected outcomes, potentially leading to more optimized patient management.The GOTIC-VTE trial Unique identifier, jRCTs031180124; Registration date, April 06, 2017.

Indexed as

Endovascular ProceduresFibrinolytic AgentsIschemic StrokeMedical FutilityPatient TransferStrokeThrombolytic TherapyAgedAged, 80 and overFemaleHumansMaleMiddle AgedRegistriesThrombectomyTreatment OutcomeFibrinolytic AgentsCollateral circulationFutile recanalizationHubIntravenous thrombolysisMechanical thrombectomySpoke

Identifiers

PMID39954040
PMCPMC11885372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.